Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.

Completed

Phase N/A Results

Trial Description

Specific aim: To test the effects of nasal expiratory positive airway pressure (EPAP) therapy on sleep apnea severity among patients with recent ischemic stroke.
Hypothesis 1: Ischemic stroke patients with sleep apnea will have less severe sleep apnea, as measured by the apnea-hypopnea index (AHI), with nasal EPAP therapy compared with a control night.
Hypothesis 2: Ischemic stroke patients will have higher mean levels of oxygen saturation with nasal EPAP therapy compared with a control night.

Conditions

Interventions

  • EPAP Device
    Other Names: Provent Sleep Apnea Therapy.
    ARM 1: Kind: Experimental
    Label: EPAP
    Description: Provent Sleep Apnea Therapy.

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Intervention: Crossover Assignment

Outcomes

Type Measure Time Frame Safety Issue
Primary Apnea-hypopnea index night 1 and night 2 No

Sponsors